Compounds > valsartan
Page last updated: 2024-08-24

valsartan and Berger Disease

valsartan has been researched along with Berger Disease in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's6 (46.15)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Bo, W; Li, L; Peng, Z; Xiaowei, L1
Chen, J; Jiang, Y; Li, T; Qu, Z; Si, R; Wang, X1
Chin, HJ; Kim, YC; Koo, HS; Yu, MY1
Chen, C; Gan, L; Li, X; Luo, H; Zhou, Q; Zhu, M1
Feng, Z; Hou, S; Hu, H; Liang, Y; Shi, W; Shi, X; Wang, L; Wang, W; Xia, Y; Xu, L; Yan, H; Ye, Z; Zhang, B; Zhang, L; Zhong, W1
Chen, F; Cheng, G; Fang, Y; Guo, Y; Li, H; Liu, D; Liu, F; Liu, L; Liu, Z; Margetts, P; Tang, L; Zhao, Z1
Choi, HY; Han, SW; Jo, YI; Kie, JH; Lee, SH; Lee, YK; Lim, SD; Moon, JY; Na, HY; Park, HC; Shin, SK; Yang, DH1
Nakanishi, K; Nozu, K; Okamoto, M; Yokoyama, N; Yoshikawa, N1
Imanishi, M; Kitabayashi, C; Konishi, Y; Maeda, I; Miyazaki, M; Morikawa, T; Nishiyama, A; Okada, N; Okumura, M; Takai, S; Ueda, M; Yoshioka, K1
Aros, C; Bertocchi, F; Campbell, R; Fagiani, L; Perna, A; Perticucci, E; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F; Viscarra, C1
Chijiwa, T; Hashimoto, K; Horino, T; Hosokawa, T; Ito, H; Sasaoka, A; Tanimoto, N; Yoshida, T1
Cheng, YL; Chow, KM; Fung, SK; Leung, CB; Li, PK; Mak, SK; Szeto, CC; Tang, AW; Wong, TY; Yu, AW; Yung, CY; Yung, JC1
Horikoshi, S; Kimura, M; Nakamura, S; Shirato, I; Suzuki, Y; Thang, NT; Tomino, Y1

Trials

9 trial(s) available for valsartan and Berger Disease

ArticleYear
Comparison of the effects of valsartan plus activated vitamin D versus valsartan alone in IgA nephropathy with moderate proteinuria.
    International urology and nephrology, 2020, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Prospective Studies; Proteinuria; Valsartan; Vitamin D; Vitamins; Young Adult

2020
Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    PloS one, 2017, Volume: 12, Issue:11

    Topics: Adult; Antihypertensive Agents; Captopril; Creatinine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Tacrolimus; Treatment Outcome; Valsartan

2017
Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy.
    Renal failure, 2018, Volume: 40, Issue:1

    Topics: Adult; Biopsy; Cell Line; Cell Proliferation; Chemokine CCL20; Chemokine CCL22; Chemokine CCL27; Chemotaxis; Coculture Techniques; Disease Progression; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Glucosides; Humans; Immunosuppressive Agents; Male; Mesangial Cells; Middle Aged; Phenols; Proteinuria; Rehmannia; T-Lymphocytes, Helper-Inducer; Transforming Growth Factor beta1; Treatment Outcome; Valsartan; Young Adult

2018
Probucol combined with valsartan in immunoglobulin A nephropathy: a multi-centre, open labelled, randomized controlled study.
    Nephrology (Carlton, Vic.), 2014, Volume: 19, Issue:1

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Probucol; Tetrazoles; Valine; Valsartan

2014
Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Nephrology (Carlton, Vic.), 2015, Volume: 20, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; China; Clopidogrel; Creatinine; Disease Progression; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Male; Platelet Aggregation Inhibitors; Proteinuria; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Valine; Valsartan

2015
Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial.
    The Korean journal of internal medicine, 2016, Volume: 31, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Blood Pressure; Creatinine; Female; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Prospective Studies; Proteinuria; Republic of Korea; Time Factors; Treatment Outcome; Valsartan

2016
Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:8

    Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antihypertensive Agents; Biopsy; Chymases; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Kidney; Linear Models; Male; Mast Cells; Prednisolone; Renal Circulation; Severity of Illness Index; Tetrazoles; Ultrasonography, Doppler; Valine; Valsartan

2008
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
    Kidney international, 2003, Volume: 63, Issue:3

    Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Chronic Disease; Cross-Over Studies; Dextrans; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan

2003
Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:5

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Double-Blind Method; Female; Glomerulonephritis, IGA; Hong Kong; Humans; Male; Tetrazoles; Valine; Valsartan

2006

Other Studies

4 other study(ies) available for valsartan and Berger Disease

ArticleYear
Increased frequency of PD-1
    Scientific reports, 2020, 01-16, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Aged; B-Lymphocytes; Benzazepines; Case-Control Studies; Female; Glomerulonephritis, IGA; Humans; Interleukins; Male; Middle Aged; Prednisone; Programmed Cell Death 1 Receptor; Receptors, CXCR5; Syndecan-1; T-Lymphocytes, Helper-Inducer; Valsartan; Young Adult

2020
Crescentic IgA nephropathy in a child: Effect of a new combination therapy.
    Pediatrics international : official journal of the Japan Pediatric Society, 2017, Volume: 59, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Child; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Lisinopril; Male; Prednisolone; Ribonucleosides; Valsartan

2017
[Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
    Nihon Jinzo Gakkai shi, 2003, Volume: 45, Issue:2

    Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Hypertension, Renal; Renin-Angiotensin System; Tetrazoles; Thiazepines; Treatment Outcome; Valine; Valsartan

2003
Effect of valsartan, an angiotensin II AT(1) receptor blocker, on the glomerular fibrosis of IgA nephropathy in ddY mice.
    Nephron, 2000, Volume: 86, Issue:3

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Fibrosis; Glomerulonephritis, IGA; Kidney Glomerulus; Mice; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan

2000